CJC-1295/Ipamorelin Blend – 5mg/5mg | 10mg/10mg (No Dac)

CJC-1295/Ipamorelin

This product is not intended for weight loss, human consumption, or veterinary use. It is sold for research purposes only. Please handle with care and follow all safety guidelines for the specific chemicals involved.

What is CJC-1295/Ipamorelin Blend?

Researchers looking to buy CJC 1295 ipamorelin blend will find this combination offers a promising approach to studying growth hormone (GH) dynamics and their physiological effects in rat research. CJC-1295, a synthetic growth hormone-releasing hormone (GHRH) analog, and Ipamorelin, a selective GH secretagogue, have been individually studied for their impacts on GH secretion and related biological processes. This CJC 1295 no dac ipamorelin formulation is verified for 99% purity through independent third-party testing.

CJC-1295 Research Findings

CJC-1295 has been shown to significantly increase GH and insulin-like growth factor I (IGF-I) levels in healthy adults, with sustained effects over extended periods. This prolonged stimulation can enhance GH secretion and IGF-I production, making the CJC 1295 ipamorelin peptide blend a valuable tool for studying GH-related functions in animal models.

Ipamorelin Research Findings

Ipamorelin, on the other hand, is known for its potent GH-releasing properties. Studies have demonstrated that Ipamorelin stimulates GH release in a dose-dependent manner, influencing growth rates and body weight in rats. Additionally, Ipamorelin has been observed to stimulate insulin release through specific pathways, highlighting its multifaceted role in endocrine regulation.

Combined Effects in Research

When used in combination, the CJC-1295/Ipamorelin blend may provide a comprehensive model for investigating GH secretion mechanisms, metabolic processes, and potential therapeutic applications. Their combined effects could offer insights into the regulation of growth and metabolism, with implications for understanding various physiological and pathological conditions. Use our peptide calculator for accurate reconstitution volumes in your research protocols.

References

• Ionescu, M., & Frohman, L. A. (2006). Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog. Journal of Clinical Endocrinology & Metabolism, 91(12), 4792–4797. https://doi.org/10.1210/jc.2006-1702
• Teichman, S. L., Neale, A., Lawrence, B., Gagnon, C., Castaigne, J. P., & Frohman, L. A. (2006). Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. Journal of Clinical Endocrinology & Metabolism, 91(3), 799–805. https://doi.org/10.1210/jc.2005-1536
• Ionescu, M., & Frohman, L. A. (2006). Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog. Journal of Clinical Endocrinology & Metabolism, 91(12), 4792–4797. https://doi.org/10.1210/jc.2006-1702
• Ionescu, M., & Frohman, L. A. (2006). Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog. Journal of Clinical Endocrinology & Metabolism, 91(12), 4792–4797. https://doi.org/10.1210/jc.2006-1702
• Ionescu, M., & Frohman, L. A. (2006). Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog. Journal of Clinical Endocrinology & Metabolism, 91(12), 4792–4797. https://doi.org/10.1210/jc.2006-1702